Known history of another primary malignancy that has not been in remission for ?1 year
In patients with a prior history of invasive malignancy, less than five years in complete remission
Patients with a history of any other malignancy, except patients with a secondary brain tumor if the patientâ€™s first malignancy has been in remission for at least 5 years from the end of treatment
History of another primary malignancy that has not been in remission for at least 2 years.
Subjects must be in primary remission
Second primary invasive malignancy that has not been in remission for greater than 2 years.
Subjects who have an uncontrolled systemic malignancy that is not in remission
History of another primary invasive cancer, hematologic malignancy, or myelodysplastic syndrome that has not been in remission for at least 1 year
History of another invasive malignancy that has not been in remission for at least 3 years
A primary malignancy which has been completely resected and in complete remission for ? 5 years
Known history of another primary malignancy that has not been in remission for ?2 years
History of a primary invasive malignancy not listed in the inclusion criteria, which has not been in remission for at least 3 years. The following are exempt from the 3 year limit:
History of another primary invasive cancer, hematologic malignancy, or myelodysplastic syndrome that has not been in remission for at least 3 years
other effectively treated malignancy that has been in remission for more than 5 years and is considered to be cured
Patients with another primary malignancy that has not been in remission for at least 3 years.
History of another primary invasive malignancy that has not been in remission for at least 3 years
Patients who have had a previous malignancy that is not in remission
Participants with history of another primary malignancy not in remission for at least 3 years
Patients who have had a previous malignancy that is not in remission
Second primary malignancy that has not been in remission for greater than 3 years. Exceptions that do not require a 3 year remission include: related non-melanoma skin cancer or resected melanoma in situ.
History of another primary malignancy that has not been in remission for at least 3 years
Prior malignancy (excluding nonmelanoma carcinomas of the skin) unless in remission for 2 years.
History of a concurrent or second malignancy, except for specified exceptions in the protocol or any other cancer that has been in complete remission for ? 5 years
the malignancy has been in remission without treatment for ? 5 years prior to enrollment, or
History of another primary malignancy that has not been in remission for 3 years
Second primary malignancy that has not been in remission for more than 3 years
History of another primary malignancy that has not been in remission for at least 3 years
Has history of a diagnosed and/or treated hematologic or primary solid tumor malignancy, unless in remission for at least 5 years prior to randomization
Subject has other prior malignancy that is not in complete remission.
Second primary invasive malignancy that has not been in remission for greater than 2 years.
